Amendment No. 1 to the Exclusive Development and Commercialization Agreement, dated as of May 11, 2001 Between InterMune, Inc. and Molichem R&D, Inc.Development and Commercialization Agreement • August 14th, 2002 • Molichem Medicines Inc • Pharmaceutical preparations
Our signatures below approve this document as Amendment No. 1 (“Amendment”) to that certain Exclusive Development and Commercialization Agreement, dated as of May 11, 2001, between InterMune, Inc. and MoliChem R&D, Inc. (the “Agreement”). All capitalized terms that are not defined in this Amendment No. 1 shall have the meaning ascribed to such capitalized terms in the Agreement.
